FibroGen (NASDAQ:FGEN) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report issued on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. FibroGen Stock Performance Shares of FGEN opened at $0.32 on Monday. FibroGen has a 1 year low of $0.30 and a 1 year high of $2.93. The […]
25 Oct 05:55 · The Markets Daily